ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $523,629 | -20.6% | 39,850 | -21.1% | 0.06% | -48.8% |
| Q1 2023 | $659,221 | -27.2% | 50,515 | -1.6% | 0.12% | -43.3% |
| Q4 2022 | $905,179 | -39.1% | 51,314 | -48.8% | 0.22% | -45.8% |
| Q2 2022 | $1,487,000 | +105.7% | 100,246 | +212.3% | 0.40% | +105.1% |
| Q1 2022 | $723,000 | +0.6% | 32,095 | -40.4% | 0.20% | -16.7% |
| Q3 2021 | $719,000 | +6.7% | 53,807 | +19.8% | 0.23% | -43.5% |
| Q1 2021 | $674,000 | +114.6% | 44,907 | +40.5% | 0.41% | +331.2% |
| Q4 2019 | $314,000 | -38.6% | 31,970 | -27.2% | 0.10% | -58.6% |
| Q2 2019 | $511,000 | +176.2% | 43,898 | +126.3% | 0.23% | +154.9% |
| Q1 2019 | $185,000 | -76.5% | 19,394 | -70.4% | 0.09% | -85.0% |
| Q2 2018 | $787,000 | +32.0% | 65,624 | +36.1% | 0.60% | +20.8% |
| Q1 2018 | $596,000 | +146.3% | 48,224 | +183.8% | 0.50% | +155.6% |
| Q3 2017 | $242,000 | +34.4% | 16,992 | +20.4% | 0.20% | +17.4% |
| Q2 2017 | $180,000 | – | 14,110 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |